Page last updated: 2024-10-29

ketoconazole and Cholera Infantum

ketoconazole has been researched along with Cholera Infantum in 8 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Treatment with fluconazole, 200 mg/day, was introduced."5.29[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996)
" The first group was dosed orally with TCBZ at a dosage of 10mg/kg and KTZ at a dosage of 10mg/kg."1.37Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole. ( Alvarez, LI; Brennan, GP; Devine, C; Fairweather, I; Hoey, E; Lanusse, CE; Trudgett, A, 2011)
"Ketoconazole adherence was 82% (G1) and 100% (G2)."1.36Retrospective analysis of the consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancer. ( Dowell, JE; Jean, GW; Keisner, SV; Shah, SR; Ussery, SM, 2010)
"Treatment with fluconazole, 200 mg/day, was introduced."1.29[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keisner, SV1
Shah, SR1
Jean, GW1
Ussery, SM1
Dowell, JE1
Devine, C1
Brennan, GP1
Lanusse, CE1
Alvarez, LI1
Trudgett, A1
Hoey, E1
Fairweather, I1
Zhou, Q1
Yan, XF1
Zhang, ZM1
Pan, WS1
Zeng, S1
Tebbe, B1
Boyvat, A1
Geilen, CC1
Wölfer, LU1
Seibold, M1
Orfanos, CE1
Nathwani, D1
Green, ST1
McGuire, W1
Goldberg, DJ1
Kennedy, DH1
Witjes, FJ1
Debruyne, FM1
Fernandez del Moral, P1
Geboers, AD1
Vanuytsel, L1
Ang, KK1
Vantongelen, K1
Drochmans, A1
Baert, L1
van der Schueren, E1
Weisman, IM1
Moreno, AJ1
Parker, AL1
Sippo, WC1
Liles, WJ1

Reviews

1 review available for ketoconazole and Cholera Infantum

ArticleYear
Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.
    World journal of gastroenterology, 2007, Nov-14, Volume: 13, Issue:42

    Topics: Benzamides; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Prescriptions; Fluoroquinolones;

2007

Trials

1 trial available for ketoconazole and Cholera Infantum

ArticleYear
Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group.
    Urology, 1989, Volume: 33, Issue:5

    Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Clinical Trials as

1989

Other Studies

6 other studies available for ketoconazole and Cholera Infantum

ArticleYear
Retrospective analysis of the consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancer.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:10

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Disease-Free Survival; Drug Interactions; Drug Resist

2010
Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Veterinary parasitology, 2011, May-11, Volume: 177, Issue:3-4

    Topics: Animals; Benzimidazoles; Drug Synergism; Drug Therapy, Combination; Fasciola hepatica; Fascioliasis;

2011
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C

1996
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
    Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Di

1989
Ketoconazole therapy for advanced prostatic cancer: feasibility and treatment results.
    The Journal of urology, 1987, Volume: 137, Issue:5

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Asthenia; Drug Administration Schedule; Drug Eruptions; Fea

1987
Gastrointestinal dissemination of coccidioidomycosis.
    The American journal of gastroenterology, 1986, Volume: 81, Issue:7

    Topics: Adult; Amphotericin B; Chylous Ascites; Coccidioidomycosis; Gastrointestinal Diseases; Humans; Ketoc

1986